Renal biopsy
When a kidney biopsy changes management and when serology can replace it, contraindications, preparing the patient (BP, antithrombotics, desmopressin), what light, immunofluorescence and electron microscopy each add, and the bleeding risks from the 2020 meta-analysis.
Tier 2Medical sciences concept
Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made
At a glance
- A biopsy is worth doing when the result would change treatment or prognosis and the kidneys are still salvageable.
- Main indications: adult nephrotic syndrome, nephritic syndrome or RPGN, unexplained AKI that isn't recovering, proteinuria over 0.5 g/day with haematuria, systemic disease with kidney involvement (lupus, vasculitis, myeloma), and transplant dysfunction.
- Serology sometimes replaces it: a positive anti-PLA2R with typical membranous nephropathy, or a confirmed genetic diagnosis of Alport syndrome.
Loading the rest of the note…
Finished reading?
Sources
- KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases (chapter updates 2024)Kidney Disease Improving Global Outcomes, 2021, chapter updates 2024
- KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)Kidney Disease Improving Global Outcomes, 2025
- KHA-CARI Guidelines (glomerular disease and CKD guidance)AU/NZKidney Health Australia - Caring for Australians and New Zealanders with Kidney Impairment
- Poggio ED et al. Systematic review and meta-analysis of native kidney biopsy complications. Clin J Am Soc Nephrol 2020;15:1595-602Clinical Journal of the American Society of Nephrology, 2020
- Chen JJ et al. Efficacy of desmopressin for post-kidney biopsy bleeding complications prevention: a systematic review with frequentist and Bayesian meta-analysis. Nephrology (Carlton) 2026;31:e70164Nephrology, 2026
- Mohandes S et al. Percutaneous native kidney biopsy complications in diabetic patients in the TRIDENT cohort. Clin J Am Soc Nephrol 2026;21:1376-85Clinical Journal of the American Society of Nephrology, 2026
- Last updated
- 14 November 2026
What changed
- 14 November 2026 Turnstile bot check on sign-in and signed-out feedback